Astellas Pharma, Inc. earnings per share and revenue

ALPMY earnings per share for the last quarter are -0.36 USD whereas the estimation was 0.05 USD which accounts for -854.17% surprise. Company revenue for the same period amounts to 3.40 B USD despite the estimated figure of 2.93 B USD. Estimated earnings per share for the next quarter are 0.16 USD, and revenue is expected to reach 2.87 B USD. Also watch annual changes over time to get a bigger picture of ALPMY earnings per share and revenue dynamics.